Erratum: Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system: Erratum.

[This corrects the article DOI: 10.7150/thno.24157.]. © The author(s).

In our paper 1 and the supplementary materials, Figure 10C and Supplementary Figure 5 should be corrected as the following Figure A1 and Figure A2.

Figure A1

(Figure 10C). Detection of cell apoptosis. Cell apoptosis was assessed by counting the number of TUNEL-positive cells in the field, and a greater level of apoptosis was observed in the DMA/pIL15 group compared to the other groups (mean ± SEM; five high power fields per slide; *, p < 0.01 DMA/pIL15 versus GS, DMA, DMA/pc3.1).

Figure A2

(Supplementary Figure 5). Toxicity assessment in vivo with pathological sections. Histological examinations of H&E-stained sections of vital organs from mice in the different treatment groups: (A) heart, (B) liver, (C) lung, (D) kidney, and (E) spleen. No significant pathological changes were detected.